Rhone Ma Holdings Berhad (KLSE:RHONEMA)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.6900
0.00 (0.00%)
At close: May 14, 2026
Market Cap153.16M +1.1%
Revenue (ttm)227.46M +8.6%
Net Income14.28M +15.1%
EPS0.05 +23.8%
Shares Out221.97M
PE Ratio13.56
Forward PEn/a
Dividend0.03 (3.62%)
Ex-Dividend DateJun 25, 2026
Volume100
Average Volume23,560
Open0.6900
Previous Close0.6900
Day's Range0.6900 - 0.6900
52-Week Range0.6050 - 0.7350
Beta0.13
RSI52.44
Earnings DateMay 20, 2026

About Rhone Ma Holdings Berhad

Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company provides diagnostic laboratory analysis and consultation services to veterinary, agriculture, and food industries; tests and diagnostics services for human healthcare; and veterinary advisory services. It also conducts research and development in biotechnology; distributes human healthcare and related products; wholesales and distributes pharmaceu... [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 205
Stock Exchange Bursa Malaysia
Ticker Symbol RHONEMA
Full Company Profile

Financial Performance

In 2025, Rhone Ma Holdings Berhad's revenue was 223.68 million, an increase of 5.81% compared to the previous year's 211.41 million. Earnings were 14.16 million, an increase of 15.07%.

Financial Statements